Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Infection control and patient safety measures addressed in nursing pedagogical projects.

Boeira ER, Souza ACSE, Pereira MS, Vila VDSC, Tipple AFV.

Rev Esc Enferm USP. 2019 Jan 31;53:e03420. doi: 10.1590/S1980-220X2017042303420. English, Portuguese.

2.

Cross-cultural adaptation of the instrument Readiness for Hospital Discharge Scale - Adult Form.

Siqueira TH, Vila VDSC, Weiss ME.

Rev Bras Enferm. 2018 May;71(3):983-991. doi: 10.1590/0034-7167-2017-0241. Portuguese, English.

3.

Reflections on Nursing Educational Advancement Within Diverse and Evolving National Cultural Contexts.

Vila V, Zhuang J, Tan E, Thorne S.

Int J Nurs Educ Scholarsh. 2018 Apr 24;15(1). pii: /j/ijnes.2018.15.issue-1/ijnes-2018-0017/ijnes-2018-0017.xml. doi: 10.1515/ijnes-2018-0017.

PMID:
29694330
4.

Cerebral Palsy: how the child's age and severity of impairment affect the mother's stress and coping strategies.

Ribeiro MF, Vandenberghe L, Prudente CO, Vila VD, Porto CC.

Cien Saude Colet. 2016 Oct;21(10):3203-3212. doi: 10.1590/1413-812320152110.17352016. Portuguese, English.

5.

Fano resonance-based highly sensitive, compact temperature sensor on thin film lithium niobate.

Qiu W, Ndao A, Vila VC, Salut R, Courjal N, Baida FI, Bernal MP.

Opt Lett. 2016 Mar 15;41(6):1106-9. doi: 10.1364/OL.41.001106.

PMID:
26977645
6.

Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma.

Reynés G, Martínez-Sales V, Vila V, Balañá C, Pérez-Segura P, Vaz MA, Benavides M, Gallego O, Palomero I, Gil-Gil M, Fleitas T, Reche E.

Anticancer Drugs. 2016 Feb;27(2):133-7. doi: 10.1097/CAD.0000000000000314.

PMID:
26574999
7.

Patterns of use and dosing of tocilizumab in the treatment of patients with rheumatoid arthritis in routine clinical practice: the ACT-LIFE study.

Balsa A, Tovar Beltrán JV, Cáliz Cáliz R, Mateo Bernardo I, García-Vicuña R, Rodríguez-Gómez M, Belmonte Serrano MA, Marras C, Loza Cortina E, Pérez-Pampin E, Vila V.

Rheumatol Int. 2015 Sep;35(9):1525-34. doi: 10.1007/s00296-015-3237-x. Epub 2015 Mar 13.

PMID:
25773655
8.

[Depressive symptoms in women with chronic pelvic pain].

Luz RA, Rodrigues FM, Vila VS, Deus JM, Lima KP.

Rev Bras Ginecol Obstet. 2014 Feb;36(2):79-83. Portuguese.

PMID:
24676016
9.

Increased circulating endothelial cells and microparticles in patients with psoriasis.

Martínez-Sales V, Vila V, Ricart JM, Vayá A, Todolí J, Nńñez C, Contreras T, Ballester C, Reganon E.

Clin Hemorheol Microcirc. 2015;60(3):283-90. doi: 10.3233/CH-131766.

PMID:
24002122
10.

Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma: prognostic value.

Reynés G, Vila V, Fleitas T, Reganon E, Font de Mora J, Jordá M, Martínez-Sales V.

PLoS One. 2013 Jul 29;8(7):e69034. doi: 10.1371/journal.pone.0069034. Print 2013.

11.

Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method.

Cabrera N, Moret A, Caunedo P, Cid AR, Vila V, España F, Aznar JA.

Haemophilia. 2013 Nov;19(6):920-5. doi: 10.1111/hae.12203. Epub 2013 Jun 4.

PMID:
23730809
12.

VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer.

Fleitas T, Martínez-Sales V, Vila V, Reganon E, Mesado D, Martín M, Gómez-Codina J, Montalar J, Reynés G.

Clin Transl Oncol. 2013 Nov;15(11):897-902. doi: 10.1007/s12094-013-1020-6. Epub 2013 Mar 5.

PMID:
23463593
13.

Assessment of the thrombin generation assay in haemophilia: comparative study between fresh and frozen platelet-rich plasma.

Vila V, Aznar JA, Moret A, Marco A, Navarro S, Vila C, España F.

Haemophilia. 2013 Mar;19(2):318-21. doi: 10.1111/hae.12044. Epub 2012 Nov 23.

PMID:
23174035
14.

Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer.

Fleitas T, Martínez-Sales V, Vila V, Reganon E, Mesado D, Martín M, Gómez-Codina J, Montalar J, Reynés G.

PLoS One. 2012;7(10):e47365. doi: 10.1371/journal.pone.0047365. Epub 2012 Oct 15.

15.

Circulating endothelial cells in patients with heart failure and left ventricular dysfunction.

Martínez-Sales V, Sánchez-Lázaro I, Vila V, Almenar L, Contreras T, Reganon E.

Dis Markers. 2011;31(2):75-82. doi: 10.3233/DMA-2011-0801.

16.

[Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre].

Martín de Carpi J, Vila V, Varea V.

An Pediatr (Barc). 2011 Oct;75(4):232-8. doi: 10.1016/j.anpedi.2011.03.011. Epub 2011 May 5. Spanish.

17.

Atorvastatin neutralises the thrombin-induced tissue factor expresion in endothelial cells via geranylgeranyl pyrophosphate.

Martínez-Sales V, Vila V, Ferrando M, Reganon E.

Cytotechnology. 2011 Jan;63(1):1-5. doi: 10.1007/s10616-010-9319-4. Epub 2010 Nov 4.

18.

[Circulating endothelial cells and microparticles in patients with antiphospholipid antibodies].

Martínez-Sales V, Vila V, Micó L, Contreras MT, Escandell A, Reganon E.

Med Clin (Barc). 2011 Apr 16;136(10):431-3. doi: 10.1016/j.medcli.2010.06.020. Epub 2010 Nov 3. Spanish.

PMID:
21051055
19.

Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma.

Reynés G, Vila V, Martín M, Parada A, Fleitas T, Reganon E, Martínez-Sales V.

J Neurooncol. 2011 Mar;102(1):35-41. doi: 10.1007/s11060-010-0290-x. Epub 2010 Jul 6.

PMID:
20607353
20.

Endoscopic dilation of gastrojejunal anastomotic strictures after laparoscopic gastric bypass. Predictors of initial failure.

Da Costa M, Mata A, Espinós J, Vila V, Roca JM, Turró J, Ballesta C.

Obes Surg. 2011 Jan;21(1):36-41. doi: 10.1007/s11695-010-0154-7.

PMID:
20396992
21.

Genetic variability of two populations of Pseudoplatystoma reticulatum from the Upper Paraguay River Basin.

de Abreu MM, Pereira LH, Vila VB, Foresti F, Oliveira C.

Genet Mol Biol. 2009 Oct;32(4):868-73. doi: 10.1590/S1415-47572009005000075. Epub 2009 Dec 1.

22.

What is the best biomarker for diagnosis of rejection in heart transplantation?

Martínez-Dolz L, Almenar L, Reganon E, Vila V, Sánchez-Soriano R, Martínez-Sales V, Moro J, Agüero J, Sánchez-Lázaro I, Salvador A.

Clin Transplant. 2009 Sep-Oct;23(5):672-80. doi: 10.1111/j.1399-0012.2009.01074.x. Epub 2009 Aug 27.

PMID:
19712083
23.

Erythrocyte membrane composition in patients with primary hypercholesterolemia.

Vayá A, Martínez Triguero M, Réganon E, Vila V, Martínez Sales V, Solá E, Hernández Mijares A, Ricart A.

Clin Hemorheol Microcirc. 2008;40(4):289-94. Erratum in: Clin Hemorheol Microcirc. 2009;41(2):149. Ricart, A [added].

PMID:
19126991
24.

Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.

Martínez-Dolz L, Almenar L, Reganon E, Vila V, Chamorro C, Andrés L, Martínez-Sales V, Moro J, Agüero J, Sánchez-Lázaro I, Salvador A.

J Heart Lung Transplant. 2008 Jul;27(7):760-6. doi: 10.1016/j.healun.2008.04.010. Epub 2008 Jun 6.

PMID:
18582806
25.

Inflammatory markers in stable heart failure and their relationship with functional class.

Sánchez-Lázaro IJ, Almenar L, Reganon E, Vila V, Martínez-Dolz L, Martínez-Sales V, Moro J, Agüero J, Ortiz-Martínez V, Salvador A.

Int J Cardiol. 2008 Oct 13;129(3):388-93. Epub 2007 Nov 26. Erratum in: Int J Cardiol. 2011 Feb 3;146(3):484.

PMID:
18022711
26.

Atorvastatin neutralizes the up-regulation of thrombospondin-1 induced by thrombin in human umbilical vein endothelial cells.

Martínez-Sales V, Vila V, Ferrando M, Reganon E.

Endothelium. 2007 Jul-Oct;14(4-5):233-8.

PMID:
17922340
27.

Inflammation, endothelial dysfunction and angiogenesis markers in chronic heart failure patients.

Vila V, Martínez-Sales V, Almenar L, Lázaro IS, Villa P, Reganon E.

Int J Cardiol. 2008 Nov 12;130(2):276-7. Epub 2007 Aug 28. Erratum in: Int J Cardiol. 2011 Feb 3;146(3):484.

PMID:
17727986
28.

Erythrocyte deformability in obesity measured by ektacytometric techniques.

Solá E, Vayá A, Santaolaria ML, Hernández-Mijares A, Réganon E, Vila V, Martínez-Sales V, Corella D.

Clin Hemorheol Microcirc. 2007;37(3):219-27.

PMID:
17726251
29.

Effect of oral anticoagulant therapy on thrombospondin-1 and von Willebrand factor in patients with stable heart failure.

Vila V, Sales VM, Almenar L, Lázaro IS, Villa P, Reganon E.

Thromb Res. 2008;121(5):611-5. Epub 2007 Aug 10.

PMID:
17692904
30.

Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems.

Gilabert-Estellés J, Ramón LA, España F, Gilabert J, Vila V, Réganon E, Castelló R, Chirivella M, Estellés A.

Hum Reprod. 2007 Aug;22(8):2120-7. Epub 2007 Jul 3.

PMID:
17609243
31.

[Optic neuropathy induced by prenatal drug or alcohol exposure].

Pons S, Zanón-Moreno V, Melo P, Vila V, Gallego-Pinazo R, Pinazo-Durán MD.

Arch Soc Esp Oftalmol. 2007 Jan;82(1):21-6. Spanish.

32.

Diagnostic usefulness of inflammatory markers in acute cellular rejection after heart transplantation.

Sánchez-Soriano RM, Almenar L, Martínez-Dolz L, Reganon E, Martínez-Sales V, Chamorro CI, Vila V, Martín-Pastor J, Villa P, Salvador A.

Transplant Proc. 2006 Oct;38(8):2569-71.

PMID:
17098005
33.

Sialic acid is an inflammation marker associated with a history of deep vein thrombosis.

Reganon E, Vila V, Martínez-Sales V, Vayá A, Mira Y, Ferrando F, Aznar J.

Thromb Res. 2007;119(1):73-8. Epub 2006 Feb 28.

PMID:
16500696
34.

The viral protein A238L inhibits cyclooxygenase-2 expression through a nuclear factor of activated T cell-dependent transactivation pathway.

Granja AG, Nogal ML, Hurtado C, Vila V, Carrascosa AL, Salas ML, Fresno M, Revilla Y.

J Biol Chem. 2004 Dec 17;279(51):53736-46. Epub 2004 Oct 7.

35.

Erythrocyte aggregation and -455G/A polymorphism of the beta-fibrinogen gene in survivors of acute myocardial infarction.

Vayá A, Breña S, Réganon E, Vila V, Martinez-Sales V, Contreras MT, Zorio E, Corella D, Aznar J.

Thromb Haemost. 2004 Jul;92(1):223-4. No abstract available.

PMID:
15213870
36.

Association between inflammation and hemostatic markers in atherothrombotic stroke.

Reganon E, Vila V, Martínez-Sales V, Vaya A, Lago A, Alonso P, Aznar J.

Thromb Res. 2003;112(4):217-21.

PMID:
14987914
37.

Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction.

Vayá A, Falcó C, Réganon E, Vila V, Martínez-Sales V, Corella D, Contreras MT, Aznar J.

Thromb Haemost. 2004 Feb;91(2):354-9.

PMID:
14961164
38.
39.

[Postoperative pain relief in patients from the perspective of nurses at an intensive care center].

Vila VS, Mussi FC.

Rev Esc Enferm USP. 2001 Sep;35(3):300-7. Portuguese.

PMID:
12442732
40.

Inflammation, fibrinogen and thrombin generation in patients with previous myocardial infarction.

Réganon E, Vila V, Martínez-Sales V, Vaya A, Aznar J.

Haematologica. 2002 Jul;87(7):740-5; discussion 745.

41.

Analysis of the stability of stored adenosine 5'-monophosphate used for bronchoprovocation.

Martínez-García MA, Perpiñá-Tordera M, Vila V, Compte-Torrero L, De Diego-Damiá A, Macián-Gisbert V.

Pulm Pharmacol Ther. 2002;15(2):157-60.

PMID:
12090789
42.

Relationship between fibrinogen protein and fibrinogen function in postmyocardial infarction patients.

Réganon E, Martínez-Sales V, Vila V, Vayá A, Martinez M, Palencia MA, Aznar J.

Thromb Res. 2001 Dec 15;104(6):413-9.

PMID:
11755951
43.

[Glutaraldehyde-induced iatrogenic rectocolitis].

Vila V, Brullet E, Montserrat A, Bella R, Campo R, Colomer L, Junquera F.

Gastroenterol Hepatol. 2001 Oct;24(8):409-10. Spanish. No abstract available.

PMID:
11674962
45.

Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes.

Vila V, Martínez-Sales V, Réganon E, Peris E, Perez F, Ruano M, Aznar J.

Haematologica. 2001 Jul;86(7):729-34.

46.

Elevated high molecular weight fibrinogen in plasma is predictive of coronary ischemic events after acute myocardial infarction.

Reganon E, Vila V, Ferrando F, Martínez-Sales V, Fayos L, Ruano M, Aznar J.

Thromb Haemost. 1999 Nov;82(5):1403-5.

PMID:
10595627
47.

Elevated thrombotic activity after myocardial infarction: A 2-year follow-up study.

Martínez-Sales V, Vila V, Réganon E, Goberna MA, Ferrando F, Palencia MA, Aznar J.

Haemostasis. 1998 Nov-Dec;28(6):301-6.

PMID:
10461012
48.

Increase in thrombin generation after coronary thrombolysis with rt-PA or streptokinase with simultaneous heparin versus heparin alone.

Réganon E, Ferrando F, Vila V, Villa P, Martínez-Sales V, Fayos L, Ruano M, Aznar J.

Haemostasis. 1998 Mar-Apr;28(2):99-105.

PMID:
10087435
49.

Anterior pituitary development and Pit-1/GHF-1 transcription factor.

de la Hoya M, Vila V, Jiménez O, Castrillo JL.

Cell Mol Life Sci. 1998 Oct;54(10):1059-66. Review.

PMID:
9817984
50.

The effect of thrombin on the dynamic exchange between intraplatelet and extraplatelet fibrinogen.

Vila V, Martínez-Sales V, Réganon E, Aznar J.

Br J Haematol. 1997 Dec;99(3):548-54.

PMID:
9401064

Supplemental Content

Support Center